Seeking Alpha

  Progenics Pharmaceuticals Inc. (PGNX) - NASDAQ

  • Derrik Lattig | Send Message 15 Mar 2013

    $PGNX making a run this morning off new earnings. Time to buy?
      PGNX vs. ETF Alternatives
      Company Description
      Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology .It develops products for the treatment of prostate cancer, for the treatment of opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States